Table 2.
TNBC relevancya | Intrinsic subtypesb | Receptor statusb |
---|---|---|
| ||
Does not include TNBC diagnoses | Luminal A | ER+ |
Luminal B | PR+ | |
HER2-enriched | ER+ and PR+ ER+ and PR+ and HER2− ER+ and PR+ and HER2+ HER2+ |
|
| ||
May include TNBC diagnosesc | ER− PR− ER− and PR− HER2− |
|
| ||
TNBC diagnoses | Basald | ER−PR−HER2− |
Abbreviations: ER – Estrogen Receptor, PR – Progesterone Receptor, TNBC – Triple Negative Breast Cancer, HER2 – Human Epidermal growth factor Receptor 2.
Breast cancer diagnoses grouping according to relevancy of TNBC.
Ways in which breast cancer diagnoses were categorized in results included in this review.
Diagnoses which did not report all three receptor statuses (ER, PR, HER2) prevent definitive determination of TNBC status.
Cancers identified as basal are assumed to be TNBC.